ASIA BEAT: No horsing around in 2014
This article was originally published in Scrip
2014 will herald a number of important developments in the pharma industry in Asia, some groundbreaking, others a culmination of ongoing processes. Either way, the Year of the Horse will be far from quiet.
You may also be interested in...
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.